We are pleased to officially announce the winner of the Quanterix Abstract Contest – Spain & Portugal Edition, held in May 2025.
After a thorough evaluation process based on the criteria outlined in the official contest terms and conditions, the selected winner is:
Dra. Aurora Pujol, in collaboration with Dra. Selena Trifunov
Neurometabolic Diseases Laboratory
IDIBELL- Hospital Duran i Reynals
The winning abstract stood out for its scientific merit, innovation, and potential impact in the field. We extend our sincere congratulations to the winner and thank all participants for their outstanding contributions.
The selection of the winner was made in accordance with the objective criteria established in the contest rules and was not influenced by commercial interests.
This contest reaffirms our commitment to supporting scientific excellence and fostering innovation across Spain and Portugal.
Special Mentions
In addition to the winning project, we would like to recognize the following researchers for their exceptional quality and innovative projects. Although they were not selected as the final winner, their work deserves special mention:
- Natalia Cullell – Fundació Docència i Recerca MutuaTerrassa
- Regina Menezes Echaniz – COFAC – Lusófona University – Research Center of Biosciences and Health Technology
- Manuel Campos-Toimil – Universidad de Santiago de Compostela
- Ana Isabel Rodríguez Pérez – Universidad de Santiago de Compostela
- Adrián Marcos Morales – Hospital Universitario 12 de Octubre
- Mario Salas Carrillo – Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC)
Related Posts
Industry Insights: Multi-omic Diagnostics
Multi-omic diagnostics are reshaping how researchers and clinicians approach complex diseases, offering deeper biological insights through the integration of multiple data types. In this interview with The Pathologist, industry experts…
Spatial Analysis
Snapshots of Health Innovation From the Edison Awards
Building the Tools Parkinson’s Disease Research Needs
A Q&A with Kishore Malyavantham, PhD, VP of R&D at Quanterix and Co-Investigator, PD-BUILD Quanterix has been named a Co-Investigator institution in PD-BUILD (Biomarker Utilization, Innovation, and Laboratory-to-Deployment), a new project…
Quanterix Named to ASAP CRN 2026 PD-BUILD Program with MJFF Support
Part of a global effort to advance Parkinson’s disease biomarkers through standardized, scalable assay development Quanterix has been selected as a Co-Investigator institution in the PD-BUILD program, part of the…
Neurology
Why biomarkers are no longer supplemental
Quanterix makes the case with ctDNA in oncology, p-tau217 in Alzheimer’s and a lab model built for longitudinal, regulatory-grade data. Biomarkers have moved from “nice-to-have” to the backbone of drug…
Neurology
Preparing The Market for Blood-Based Biomarkers
Shana Tetrault, PhD, Director of Product Marketing at Quanterix, outlined strategies for integrating blood-based biomarkers into routine clinical care pathways, ensuring minimal disruption for patients and clinicians. Watch the full…
Neurology
Challenges of Positioning an Ultra-Sensitive Platform
Shana Tetrault, PhD, Director of Product Marketing at Quanterix, discussed challenges in positioning Simoa in the precision health market, stressing its accuracy and reliability in diverse populations. Watch the full…
Neurology
Translating Complex Scientific Findings into Actionable Insights
Shana Tetrault, PhD, Director of Product Marketing at Quanterix, discussed translating complex scientific findings into actionable insights for healthcare providers and stakeholders, emphasizing the importance of early disease detection. Watch…